The cheapest way to get a GLP-1 receptor agonist, a class of medications that includes semaglutide and tirzepatide, depends on which bucket you fall into. If you qualify for an income-based assistance program, the cheapest path is $0. If your insurance actually covers treatment, the cheapest verified path I found was Found starting at $17 per month plus whatever your plan still leaves you to pay. If you are paying cash and want the cleanest brand-name self-pay math, Zepbound is the clear winner right now at $299 to $449 per month depending on dose. [3] [6] [11]
That is the useful short answer. The harder part is that cheap GLP-1 access in 2026 is full of fake simplicity. A price can be low because it is an intro month. It can be low because the membership fee excludes medication. It can be low because the product is compounded rather than FDA-approved. Or it can be low because the company never tells you the dose on the public pricing page, which makes price-per-mg math impossible.
This guide is built for the person who wants the actual numbers, not a soft-focus roundup. I verified live manufacturer, telehealth, and FDA source pages before writing this. If you want the broader context first, read our telehealth comparison, brand vs. compounded guide, insurance coverage guide, and semaglutide guide.
The Fast Ranking
If you want the ranking before the nuance:
- Cheapest if you qualify: Novo Nordisk Patient Assistance Program at $0 for eligible patients. [3]
- Cheapest if your insurance already works: Found insurance membership from $17 per month, with copays, coinsurance, and deductibles on top. [11]
- Cheapest with commercial insurance plus manufacturer savings: Wegovy or Ozempic can drop to $25 per month for eligible commercially insured patients. [4] [5]
- Cheapest transparent self-pay brand option: Zepbound at $299 for 2.5 mg, $399 for 5 mg, and $449 for 7.5 mg to 15 mg under Lilly’s current self-pay pricing. [6]
- Cheapest medication-included telehealth bundle I could verify: Noom Microdose GLP-1 at $79 for the first 4 weeks, then $199 per month when billed every 12 weeks. [8]
That ranking changes if your goal is specifically FDA-approved brand medication rather than the lowest sticker price. In that narrower lane, Zepbound usually wins the self-pay comparison, and manufacturer savings plus existing insurance usually wins the insured comparison. [4] [5] [6]
How I Calculated “Cheapest”
This article uses one simple rule: I only ranked prices that were posted on a source I could verify on April 7, 2026.
For price per mg, I used the posted one-month price divided by the total monthly milligrams at the public dose. That means some rows have a real number and some rows say not posted publicly. That is not me dodging the work. That is me refusing to invent dose math when the seller will not publish the dose cleanly.
For telehealth bundles, I treated the posted monthly program fee as the starting number and then noted whether medication was included, excluded, or unclear.
For compounded paths, I ranked cost and risk separately because FDA says compounded GLP-1s are not FDA-approved and should be used only when a patient’s medical needs cannot be met by an FDA-approved drug, or when the approved drug is not commercially available. [1]
Master Pricing Table
Screenshot this part.
| Access pathway | Monthly cost range I verified | Price per mg | Medication form | Includes prescriber? | Rx required? |
|---|---|---|---|---|---|
| Novo Nordisk PAP | $0 if eligible [3] | Not meaningful | Brand diabetes-labeled products | No, this is assistance not prescribing | Yes |
| Found insurance path | Starts at $17/month, plus copays, coinsurance, and deductibles [11] | Not posted publicly | Depends on what is prescribed | Yes | Yes |
| Wegovy or Ozempic with eligible commercial savings | As low as $25/month [4] [5] | Not meaningful because insurer cost sharing varies | Brand pen or tablet, depending product | No | Yes |
| Zepbound self-pay 2.5 mg | $299/month [6] | About $29.90/mg | Brand injectable | No | Yes |
| Zepbound self-pay 5 mg | $399/month [6] | About $19.95/mg | Brand injectable | No | Yes |
| Zepbound self-pay 7.5 mg | $449/month [6] | About $14.97/mg | Brand injectable | No | Yes |
| Zepbound self-pay 10 mg | $449/month [6] | About $11.23/mg | Brand injectable | No | Yes |
| Zepbound self-pay 12.5 mg | $449/month [6] | About $8.98/mg | Brand injectable | No | Yes |
| Zepbound self-pay 15 mg | $449/month [6] | About $7.48/mg | Brand injectable | No | Yes |
| Wegovy direct-pay offers | Starting at $149/month for Wegovy pill 1.5 mg; starting at $199/month for Wegovy pen intro offers [4] | Dose-dependent; intro offers make long-term math messy | Brand oral or injectable | No | Yes |
| Ro Body membership | $45 first month, then $145/month; medication separate [7] | Not posted publicly | Brand-focused prescribing | Yes | Yes |
| Noom GLP-1 Rx | $129 for the initial 4-week supply, then $279/month; medication included if prescribed [8] | Not posted publicly | Telehealth bundled medication path | Yes | Yes |
| Noom Microdose GLP-1 Rx | $79 for the first 4 weeks, then $597 every 12 weeks, or $199/month [8] | Not posted publicly | Lower-dose telehealth bundled medication path | Yes | Yes |
| Calibrate Metabolic Reset | $199/month with an initial 3-month commitment; medication and labs are separate [9] | Not meaningful because medication is separate | Insurance-first coaching program | Yes | Yes |
| Found self-pay starting plan | Starts at $49/month; some plans still add medication cost or insurance copay obligations [10] | Not posted publicly | Mixed plan structures | Yes | Yes |
| Hims Wegovy through Hims | Standard rates listed at $649/month on a 3-month plan or $599/month on a 6-month plan after the promo period [12] | Not posted publicly | Brand Wegovy through telehealth | Yes | Yes |
Two rows need extra honesty.
First, Found can be truly cheap if your insurance is good, but the public pages still leave enough plan variation that you should treat the starting number as the floor, not the finished bill. Found says the insurance membership starts at $17 per month and that copays, coinsurance, and deductibles may still apply. On its main program page, it also says copay is typically around $30 for most members. [10] [11]
Second, Wegovy’s price picture changed in 2026. Novo’s current page shows direct-pay starting prices for both the new Wegovy pill and the pen, which is very different from the old era where the main number people saw was brand retail sticker shock. [4] The catch is that some of those numbers are introductory or dose-specific, so Zepbound still wins on transparent long-term self-pay math.
What Each Cheap Tier Actually Buys You
Tier 1: $0 to $25 per month
This is the bucket people want, but it is not a general public price.
The $0 route is an income-qualified assistance path. NovoCare says approved patients may qualify to receive free medicine and that there is no registration charge or monthly fee for participating. [3] That is real, but it is also narrow. It is not a universal Wegovy-for-everyone hack.
The $25 route is the manufacturer-savings route for eligible commercially insured patients. Wegovy’s current savings page says eligible commercially insured patients can pay as little as $25 per month, and Ozempic’s current savings page says the same thing for eligible commercially insured patients with coverage. [4] [5] Useful, yes. Universal, no.
If you are in this bucket, the practical move is simple: exhaust assistance and savings before you pay cash for a telehealth membership.
Tier 2: $17 to about $80 per month
This is the good-insurance zone.
Found’s insurance page says the membership starts at $17 per month, and its main program page says the typical copay is around $30 for most members. [10] [11] Noom’s branded-med telehealth path is also relatively low on paper at $69 for a 30-day trial, then $99 per month, but the medication is filled through your own pharmacy, so the pharmacy bill is still separate. [8]
This is why “membership fee” can be a trap phrase. A low monthly membership fee does not tell you what the drug will cost at the pharmacy counter.
Tier 3: $149 to $279 per month
This is where the market gets interesting.
Novo’s current Wegovy pricing page now shows Wegovy pill starting at $149 per month for the 1.5 mg dose and the Wegovy pen starting at $199 per month on intro pricing for lower starter doses. [4] Noom’s full-dose bundled GLP-1 program starts at $129 for the initial 4-week supply, then $279 per month, with medication included if prescribed. Its microdose path lands at $199 per month once you normalize the 12-week billing cycle. [8]
This is the part many comparison pages flatten too much. A $149 oral brand intro, a $199 bundled microdose program, and a $199 pen intro month are not interchangeable products.
Tier 4: $299 to $449 per month
This is the cleanest self-pay brand zone.
Lilly’s current Zepbound page is unusually transparent. It lists $299 per month for 2.5 mg, $399 for 5 mg, and $449 for 7.5 mg, 10 mg, 12.5 mg, and 15 mg under the current self-pay program. [6] Because the doses are public, you can do real price-per-mg math:
- 2.5 mg weekly: about $29.90 per mg
- 5 mg weekly: about $19.95 per mg
- 7.5 mg weekly: about $14.97 per mg
- 10 mg weekly: about $11.23 per mg
- 12.5 mg weekly: about $8.98 per mg
- 15 mg weekly: about $7.48 per mg [6]
If you are paying cash and want the cleanest brand-name route, this is the benchmark every other self-pay option has to beat.
Cheapest Is Not Always Safest
This is where the article needs to be blunt.
FDA says compounded GLP-1s are not FDA-approved, do not undergo FDA review for safety, effectiveness, or quality before marketing, and should be used only when a patient’s medical needs cannot be met by an FDA-approved drug. FDA also warns about improper storage during shipping, including compounded injectables arriving warm or with inadequate ice packs. [1]
That matters because some of the cheapest-looking GLP-1 offers in 2026 are cheap for a reason:
- the medication is compounded rather than FDA-approved
- the program never states the exact dose publicly
- the price is an intro month, not the refill month
- the monthly fee excludes medication
That does not mean every compounded path is automatically wrong. It means you should stop pretending the comparison is apples to apples. Brand products come with evidence tied to the exact approved product, including about 14.9% mean weight loss at 68 weeks with semaglutide 2.4 mg in STEP 1 and about 20.9% mean weight loss at 72 weeks with tirzepatide 15 mg in SURMOUNT-1. [14] [15] That evidence package is part of what you are buying when you choose a brand-name product.
Which Cheap Option Fits Your Situation
If you have insurance that covers the drug
Start with the lowest-friction insured path, not the lowest telehealth ad.
- Check whether a manufacturer savings card drops the fill to $25 per month. [4] [5]
- If you need prescribing help, compare Found, Ro, and Noom’s branded-med path. [7] [8] [11]
- If your insurer prefers one brand, do not overpay for a more expensive membership just to ask for the wrong drug first.
If insurance denied you
Do not jump straight to compounding because the first answer was no.
- Read our insurance coverage guide.
- Re-check whether the denial was a documentation problem or a real exclusion.
- If you still need cash pay, compare transparent brand pricing before you pay for a bundled compounded plan.
In plain English: try to convert the denial before you convert to a riskier product.
If you have no insurance
The best self-pay order is usually:
- Zepbound self-pay if you want the clearest brand pricing. [6]
- Wegovy direct-pay offers if the posted dose-specific price works for your actual dose. [4]
- Medication-included telehealth bundles such as Noom if you value convenience more than perfectly clean brand math. [8]
- Compounded paths only after you have read our brand vs. compounded guide and understand exactly what you are trading away.
If you may qualify for income-based help
Check assistance first. Not last.
NovoCare says approved patients in its PAP may qualify to receive free medicine, with no registration charge or monthly fee. [3] If you qualify, every self-pay comparison beneath that number is irrelevant.
The Three Mistakes That Waste the Most Money
1. Comparing membership fees instead of total treatment cost
Ro’s membership is $45 for the first month, then $145 per month, and Calibrate is $199 per month with an initial 3-month commitment, but both still separate the medication story from the membership story in different ways. [7] [9] A cheap membership can still lead to an expensive total bill.
2. Letting an intro month fool you
Noom, Wegovy direct-pay offers, and some telehealth programs all use starter pricing that looks nicer than the refill math. [4] [8] Always ask what month three looks like, not just month one.
3. Treating every semaglutide offer as the same product
Hims’ own semaglutide cost explainer says semaglutide costs can range from $200 to $2,000 per month depending on the version and where you get it. [13] That spread exists because semaglutide is not one shopping-cart item. It can mean a brand pen, a brand tablet, a compounded product, or a telehealth bundle with completely different evidence and oversight.
Bottom Line
If you want the cleanest one-sentence answer, it is this:
The cheapest verified GLP-1 in 2026 is an assistance program at $0, the cheapest realistic insurance-backed path starts around $17 to $25 per month, and the cheapest transparent self-pay brand route is Zepbound at $299 to $449 per month depending on dose.
The more important sentence is this:
Do not let a cheap number do all the thinking for you. A low price can reflect better insurance, better manufacturer support, or better direct-pay pricing. It can also reflect a compounded product, an intro month, or a deliberately incomplete pricing page.
If you want more cost breakdowns like this, join the newsletter. We track the pricing changes, shortage-policy shifts, and insurance moves that actually change what people pay.
Last reviewed: April 7, 2026
